Vera Therapeutics Grants Inducement Awards to New Employees in Accordance with Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics, a biopharmaceutical company based in Brisbane, California, recently announced the granting of inducement awards to new employees, including their new Chief Operating Officer, David Johnson.The awards consist of non-qualified stock options and restricted stock units, totaling over 300,000 shares of Class A common stock.These grants were approved by the Compensation Committee as inducements to secure the new employees’ employment, in compliance with Nasdaq Listing Rule 5635(c)(4).
As of the writing of this article, Vera Therapeutics’ share price stands at $35.63, representing a decrease of 19.15% in the past 90 days.Despite this decline, the company continues to attract top talent through inducement awards, demonstrating confidence in their growth potential.
Comments